Chronic graft-versus-host disease

Stephanie J. Lee, Georgia Boyce Vogelsang, Mary E D Flowers

Research output: Contribution to journalArticle

Abstract

Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with local or low-dose systemic immunosuppression and do not affect long-term survival. In contrast, more severe forms of chronic GVHD require intensive medical management and adversely affect survival. This report reviews current concepts of the pathogenesis, clinical risk factors, classification systems, organ manifestations, and available treatments for chronic GVHD. It also provides a comprehensive listing of the published clinical trials aimed at prevention and primary treatment of chronic GVHD.

Original languageEnglish (US)
Pages (from-to)215-233
Number of pages19
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Volume9
Issue number4
DOIs
StatePublished - Apr 2003

Fingerprint

Graft vs Host Disease
Stem Cell Transplantation
Primary Prevention
Immunosuppression
Clinical Trials
Therapeutics

Keywords

  • Allogeneic stem cell transplantation
  • Chronic graft-versus-host disease

ASJC Scopus subject areas

  • Transplantation

Cite this

Chronic graft-versus-host disease. / Lee, Stephanie J.; Vogelsang, Georgia Boyce; Flowers, Mary E D.

In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Vol. 9, No. 4, 04.2003, p. 215-233.

Research output: Contribution to journalArticle

@article{36e7b0a07df947c7b38d16ead3c37cf2,
title = "Chronic graft-versus-host disease",
abstract = "Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with local or low-dose systemic immunosuppression and do not affect long-term survival. In contrast, more severe forms of chronic GVHD require intensive medical management and adversely affect survival. This report reviews current concepts of the pathogenesis, clinical risk factors, classification systems, organ manifestations, and available treatments for chronic GVHD. It also provides a comprehensive listing of the published clinical trials aimed at prevention and primary treatment of chronic GVHD.",
keywords = "Allogeneic stem cell transplantation, Chronic graft-versus-host disease",
author = "Lee, {Stephanie J.} and Vogelsang, {Georgia Boyce} and Flowers, {Mary E D}",
year = "2003",
month = "4",
doi = "10.1053/bbmt.2003.50026",
language = "English (US)",
volume = "9",
pages = "215--233",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Chronic graft-versus-host disease

AU - Lee, Stephanie J.

AU - Vogelsang, Georgia Boyce

AU - Flowers, Mary E D

PY - 2003/4

Y1 - 2003/4

N2 - Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with local or low-dose systemic immunosuppression and do not affect long-term survival. In contrast, more severe forms of chronic GVHD require intensive medical management and adversely affect survival. This report reviews current concepts of the pathogenesis, clinical risk factors, classification systems, organ manifestations, and available treatments for chronic GVHD. It also provides a comprehensive listing of the published clinical trials aimed at prevention and primary treatment of chronic GVHD.

AB - Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with local or low-dose systemic immunosuppression and do not affect long-term survival. In contrast, more severe forms of chronic GVHD require intensive medical management and adversely affect survival. This report reviews current concepts of the pathogenesis, clinical risk factors, classification systems, organ manifestations, and available treatments for chronic GVHD. It also provides a comprehensive listing of the published clinical trials aimed at prevention and primary treatment of chronic GVHD.

KW - Allogeneic stem cell transplantation

KW - Chronic graft-versus-host disease

UR - http://www.scopus.com/inward/record.url?scp=0042118920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042118920&partnerID=8YFLogxK

U2 - 10.1053/bbmt.2003.50026

DO - 10.1053/bbmt.2003.50026

M3 - Article

C2 - 12720215

AN - SCOPUS:0042118920

VL - 9

SP - 215

EP - 233

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 4

ER -